Back to search

Sweden· SE-20091006000174

Twynsta 80 mg/10 mg Tablett

A medicinal product containing amlodipine + telmisartan, registered in Sweden by Boehringer Ingelheim International GmbH.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedTwynsta 80 mg/10 mg TablettATC—REGISTER NO.SE-20091006000174PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Amlodipine + Telmisartan
Manufacturer
Boehringer Ingelheim International GmbH
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20091006000174

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Amlodipine + telmisartan in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All amlodipine + telmisartan products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Austria · Telmisartan/Amlodipin Krka
  • Bulgaria · Актелсар Дуо, Равентон
  • Czechia · Tamloset, Telassmo
  • Germany · Actelsar Duo, Telmisartan/Amlodipin 089pharm
  • Estonia · Mixor, Teldipin
  • Spain · Telmisartán/Amlodipino Krka, Telmisartán/Amlodipino Teva
  • France · Telmisartan/Amlodipine Arrow
  • Greece · Cardynsta
  • Hungary · Arettan, Cotanydon
  • Iceland · Twynsta
  • Liechtenstein · Twynsta
  • Lithuania · Raventon
  • Latvia · Mixor, Raventon
  • Norway · Twynsta
  • Poland · Telam, Teldipin
  • Portugal · Amlodipina + Telmisartan Generis, Amlodipina + Telmisartan Krka
  • Romania · Telassmo
  • Slovenia · Telassmo
  • Slovakia · Mixor, Teldipin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/be9898fb-e93f-4d2e-9bcd-2d7b522cb02e
GET /v1/drugs/be9898fb-e93f-4d2e-9bcd-2d7b522cb02e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "EPAR",
    "EMA"
  ],
  "se_npl_id": "20091006000174",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20091006000174",
  "product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/twynsta-epar-product-information_sv.pdf"
}

See everything about amlodipine + telmisartan.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.